Viewing Study NCT02924233


Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2025-12-30 @ 3:58 PM
Study NCT ID: NCT02924233
Status: WITHDRAWN
Last Update Posted: 2017-08-28
First Post: 2016-09-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer
Sponsor: Symphogen A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module